RNA Treatments and Vaccines for Infectious Disease Response
14 Sep, 2020 | Newsletters
RNA-based genetic vaccines may represent the most promising approach for the rapid development and deployment of a COVID-19 vaccine. This symposium discusses the current landscape and the opportunities RNA treatments compared to DNA and conventional vaccines. Speakers provide an introductory overview of RNA platform technologies; future pandemic preparedness; and the Target Product Profile (TPP) for RNA vaccines. Dr. Andy Geall – What is Required in a Successful mRNA Vaccine Program – Recording Dr. Bijoyita Roy – The Anatomy of an mRNA and its Synthesis In Vitro – Recording Dr. Lloyd Jeffs – A Framework for Developing RNA Medicine – Recording Dr. Yvonne Perrie – Delivery Options for RNA: Exploiting Nanoparticles – Recording Dr. Andy Geall – RNA Vaccine Demonstration – Recording CONTACT US FOR A FREE DEMO NOW NANOASSEMBLR ON DEMAND WEBINARS Is RNA Medicine the Next Paradigm Shift? PNI-CRS Local Chapter This talk will highlight unique features of EVs for RNA delivery and discuss novel approaches that may contribute to the development of more efficient EV-based RNA delivery systems. Use of PNI Microfluidics to Manufacture GMP Quality siRNA Nanoparticles Sirnaomics, first company to use the NanoAssemblr® GMP System with NxGen technology to produce nanoparticles containing 2 siRNAs under GMP conditions discusses their work. Lipid Based Nanomedicine – Challenges that Lead to Solutions Dr. Bally discusses 35 years of research and new nanomedicines, mainly Myocet- for metastatic breast cancer, Marqibo- for relapsed ALL & Vyxeos, for high-risk AML. Small molecule delivery systems prepared with microfluidics This talk explores the ways that the efficacy of a small molecule drug can be increased, both through the production, and microfluidic control over the development of a suitable delivery system. |
NANOASSEMBLR DEMONSTRATION VIDEOS |
NanoAssemblr Ignite Demo Ignite with NxGen microfluidics reproducibly generates optimal particles through a single mixer across scales, saving time and money. CLICK HERE TO WATCH NOW NanoAssemblr Blaze Demo With NanoAssemblr Blaze, important studies can be conducted efficiently with a process that mirrors a clinical scale implementation. CLICK HERE TO WATCH NOW NanoAssemblr GMP Demo Configurable & modular system that enables manufacturing scales 200 ml to greater than 100 L. CLICK HERE TO WATCH NOW |